Replies to post #135923 on Innovation Pharmaceuticals Inc (IPIX)

[ericseb2003]

I hear you. It's frustrating that Kevetrin has taken so long to advance through P1, and in the meantime we're seeing a lot of developments by our competition, particularly in the CAR-T and TCR cancer immunotherapy space (which have achieved amazing results so far in early clinical trials for various hematological (blood) cancers, but not yet proven in solid tumors - also some issues with side effects and lasting results).

However, it is what it is. Kevetrin has tremendous potential based on pre-clinical work, but it's going to take at least a 1.5 years, imho, before we get enough P2 data readouts to make a substantive call on its impact on humans. Have to hang our hats on B and P in the meantime.

Have to run, have a good one.

[bradfordbros]

I thought any disclosure concerning the Dana-Farber trial of Kevetrin could only be released with their permission. We have all had to endure the frustrations of not knowing what we would like to know but for everybody's protection that is the point of a trial.

I am patently optimistic and don't allow mind games to alter my faith on the subject.